PHO-COG-FALLON-ANBL00B1; Neuroblastoma Biology Studies
S
Sandeep Batra, MD
Primary Investigator
Not Recruiting
30 years or below
All
Phase
N/A
3 Locations
Brief description of study
This research trial studies biomarkers in tumor tissue samples from patients with newly diagnosed neuroblastoma or ganglioneuroblastoma.
Detailed description of study
This research trial studies biomarkers in tumor tissue samples from patients with newly diagnosed neuroblastoma or ganglioneuroblastoma.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Neuroblastoma
-
Age: 30 years or below
-
Gender: All
Inclusion Criteria
Newly diagnosed with suspected neuroblastoma, suspected ganglionneuroblastoma
Exclusion Criteria
Patients with relapsed neuroblastoma who ere not enrolled on ANBL00B1 at original diagnosis
Additional Information:Newly diagnosed with suspected neuroblastoma, suspected ganglionneuroblastoma
Exclusion Criteria
Patients with relapsed neuroblastoma who ere not enrolled on ANBL00B1 at original diagnosis
Participants will not be paid for their participation.
Updated on
01 Aug 2024.
Study ID: 1011003226 (0012-27)
